$HUN

Wells Fargo cuts Huntsman stock price target on weak construction demand

Wells Fargo reduced its price target for Huntsman (NYSE:HUN) to $9.00 from $11.00, citing weak construction demand and margin pressures. The stock trades at $8.84, below InvestingPro’s Fair Value of $10.58. Wells Fargo maintained its Q3 2026 EBITDA estimate at $115 million but lowered its 2026 and 2027 EBITDA estimates. Huntsman's Q2 2026 earnings beat expectations, but its stock declined due to leverage concerns.

Original reporting
Published Oct 6, 2026, 10:36 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 10:53 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$HUN
Bearish
high confidence
Mentioned
$HUN
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HUNBearishHigh
01

Why it matters

The downgrade may trigger short-term selling, though earnings beat provides some support.

02

Market read

Analyst price target reduction is the primary new information, offering a clear trading signal for Huntsman.

03

What to watch

Recent earnings beat and pricing actions in polyurethanes could offset demand concerns.

Relevance 6/10Novelty 7/10Timing: same-day

Background

Wells Fargo maintains earnings estimates but reduces price target due to margin pressure and weak construction demand.

Company-level read

Ticker impact

$HUNBearishHigh confidence
Context

Wells Fargo cut Huntsman's price target to $9.00 from $11.00 citing weak construction demand and margin pressure.

Expected impact

downward pressure as the market prices in the reduced target

Evidence & confidence

Target cut is a fresh analyst action that typically leads to short-term sell pressure.

Market effects

Potentially negative for specialty chemicals sector as construction demand weakness may affect peers.

Limited to U.S. listed specialty chemicals exposure.

Modest; reflects broader construction slowdown concerns.

Counterpoint

If construction demand rebounds faster than expected, the target cut may be premature.

Key entities

  • Wells Fargo

    Equity research firm issuing the price target cut.

  • Huntsman Corp.

    Specialty chemicals manufacturer subject of the analyst downgrade.

Related articles

$HUNMed

Jefferies cuts Huntsman stock price target on European challenges

Jefferies reduced its price target for Huntsman Corp. (NYSE:HUN) to $11 from $16, citing European challenges but maintaining a Buy rating. The stock trades at $8.57, with potential upside. Huntsman's Q3 outlook is supported by industrial activity, but Europe faces gas costs and soft demand. The company expects $400M in synergies from its Olin merger. Q2 2026 earnings beat expectations, with revenue at $1.66B and adjusted EPS at $0.20.

$OLNHighAI 9/10

Olin, Huntsman Merger of Equals Clears U.S. Antitrust Hurdle

Olin (OLN) and Huntsman (HUN) cleared a U.S. antitrust hurdle for their all-stock merger, expected to create a $12.5B chemicals company with $400M in cost synergies. The deal, targeting 1H 2027 completion, still needs regulatory approvals. OLN shares fell 32.2% and HUN dropped 8.6% over the past year.

$OLNHighAI 9/10

Olin and Huntsman merger clears antitrust waiting period

Olin (OLN) and Huntsman (HUN) cleared the U.S. antitrust waiting period for their proposed merger. The milestone satisfies one closing condition, but additional regulatory approvals and customary closing conditions are still required. Olin is a chemical manufacturer and ammunition producer, while Huntsman is a diversified chemicals company with $6B in 2025 revenue.

$OLNMedAI 9/10

Olin Corporation; Huntsman Corporation: OLIN and HUNTSMAN Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger

Olin (OLN) and Huntsman (HUN) announced the expiration of the HSR Act waiting period for their proposed merger, satisfying a key closing condition. Shareholders approved the transaction, but regulatory approvals are still required. Olin is a chemical and ammunition manufacturer, while Huntsman is a diversified chemical producer with 2025 revenues of $6 billion.